These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11429028)

  • 1. Hepatitis B in transplantation.
    Bain VG
    Transpl Infect Dis; 2000 Dec; 2(4):153-65. PubMed ID: 11429028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
    Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG
    Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.
    Liu CJ; Lai MY; Lee PH; Chou NK; Chu SH; Chen PJ; Kao JH; Jen YM; Chen DS
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1001-8. PubMed ID: 11595064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
    Pérez-Grande R; Gutiérrez-Zufiaurre N; Muñoz-Criado S; Blázquez de Castro AM; Vázquez López L; González San Martín F; García Rodríguez JA; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 2009 May; 64(1):80-2. PubMed ID: 19304434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience.
    Malik MU; Ucbilek E; Trilianos P; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Apr; 15(2):183-188. PubMed ID: 27212251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine.
    Tsai MK; Lai MY; Hu RH; Lee CJ; Lee PH
    Transplant Proc; 2000 Nov; 32(7):1935-6. PubMed ID: 11120008
    [No Abstract]   [Full Text] [Related]  

  • 8. A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor.
    Sobhonslidsuk A; Ungkanont A
    World J Gastroenterol; 2007 Feb; 13(7):1138-40. PubMed ID: 17373754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Karlas T; Hartmann J; Weimann A; Maier M; Bartels M; Jonas S; Mössner J; Berg T; Tillmann HL; Wiegand J
    Transpl Infect Dis; 2011 Jun; 13(3):299-302. PubMed ID: 21159112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis.
    Mas A
    Dig Liver Dis; 2009 May; 41 Suppl 2():S191-4. PubMed ID: 19482256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
    Hashino S; Nozawa A; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Hige S; Asaka M
    Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant.
    Wai CT; Prabhakaran K; Wee A; Lee YM; Dan YY; Sutedja DS; Mak K; Isaac J; Lee KH; Lee HL; Da Costa M; Lim SG
    Transplant Proc; 2004 Oct; 36(8):2313-4. PubMed ID: 15561234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.
    Mutimer D; Pillay D; Dragon E; Tang H; Ahmed M; O'Donnell K; Shaw J; Burroughs N; Rand D; Cane P; Martin B; Buchan S; Boxall E; Barmat S; Gutekunst K; McMaster P; Elias E
    J Hepatol; 1999 Apr; 30(4):715-21. PubMed ID: 10207815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
    Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
    Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
    Lin CC; Yong CC; Chen CL
    World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation.
    Picardi M; Selleri C; De Rosa G; Raiola A; Pezzullo L; Rotoli B
    Bone Marrow Transplant; 1998 Jun; 21(12):1267-9. PubMed ID: 9674862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.